Etoricoxib D4
| Product Name | Etoricoxib D4 |
|---|---|
| Alternate Names | Etoricoxib Stable Isotopes, Stable Isotopes of Etoricoxib |
| CAT No. | CS-O-03250 |
| CAS No. | 1131345-14-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 362.87 g/mol |
| Mol. For. | C₁₈H₁₁D₄ClN₂O₂S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Etoricoxib |
| Purity | 95% |
| Smileys | CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C |
| Canonical Smiles | CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C |
| InchIKey | MNJVRJDLRVPLFE-KDWZCNHSSA-N |
| Inchl | InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3/i5D,6D,7D,8D |
| IUPAC | 5-chloro-2-(6-methylpyridin-3-yl)-3-(2,3,5,6-tetradeuterio-4-methylsulfonylphenyl)pyridine |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Etoricoxib D4 is a deuterated form of etoricoxib, which is a selective COX-2 inhibitor used for the treatment of various types of pain, including osteoarthritis, rheumatoid arthritis, and chronic low back pain. Etoricoxib D4 is used in research and clinical studies to determine the pharmacokinetics and pharmacodynamics of etoricoxib and its effects on the human body.
Etoricoxib D4 works by inhibiting the activity of COX-2 enzymes, which are responsible for producing prostaglandins, a group of chemicals that cause inflammation, pain, and fever. By blocking the production of prostaglandins, etoricoxib D4 helps to reduce inflammation and alleviate pain.
Chemically, etoricoxib D4 is a white crystalline powder that is soluble in organic solvents such as methanol and ethanol. It has a molecular weight of 389.42 g/mol and a melting point of 155-157°C. Etoricoxib D4 is stable under normal storage conditions and has a shelf life of several years.
In terms of dosage, etoricoxib D4 is typically administered orally in tablet form, with a recommended dose of 60 mg once daily for osteoarthritis and rheumatoid arthritis, and 90 mg once daily for chronic low back pain. However, the dosage may vary depending on the patient's age, weight, and medical condition.
Overall, etoricoxib D4 is a useful tool for researchers and clinicians in studying the effects of etoricoxib on the human body and in developing new treatments for pain and inflammation.
Get an Instant Quote
Related Compounds
Etoricoxib 13C6 | Etoricoxib 13CD3 | Etoricoxib D3 |